Ofloxacin otic solution 0.3% [Floxin Otic Singles] has been launched in the US by Daiichi Pharmaceutical.

Source: Inpharma, Volume 1, Number 1437, 2004-05-15 , pp. 22-22(1)

Publisher: Adis International

Keywords: Daiichi-Pharmaceutical; Development-status; Ofloxacin, therapeutic use; Otorhinolaryngological-infections, treatment; Product-launches

Document Type: Short communication

Publication date: 2004-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers